Novus Biologicals™ NAT8 Recombinant Protein Antigen

Description

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

A recombinant protein antigen with a N-terminal His6-ABP tag corresponding to human NAT8. Source: E.coli Amino Acid Sequence: DSEHRRQGIAKALVRTVLQFARDQGYSEVILDTGTIQLSAMALYQSMGFKKTGQSFFCV The NAT8 Recombinant Protein Antigen is derived from E. coli. The NAT8 Recombinant Protein Antigen has been validated for the following applications: Antibody Competition.

Specifications

• Gene ID (Entrez): 9027
• Purification Method: >80% by SDS-PAGE and Coomassie blue staining
• Common Name: NAT8 Recombinant Protein Antigen
• Content And Storage: Store at −20°C. Avoid freeze-thaw cycles.
• Formulation: PBS and 1M Urea, pH 7.4.
• For Use With (Application): Blocking/Neutralizing, Control
• Gene Alias: Camello-like protein 1, CML1, EC 2.3.1, EC 2.3.1.-, GLAkidney- and liver-specific gene product, Hcml1, N-acetyltransferase 8, N-acetyltransferase 8 (GCN5-related, putative), probable N-acetyltransferase 8, TSC501N-acetyltransferase 8 (camello like), TSC51
• Gene Symbol: NAT8
• Label Type: Unlabeled
• Product Type: Recombinant Protein Antigen
• Quantity: 100 μL
• Regulatory Status: RUO
• Source: E.coli
• Specific Reactivity: This recombinant antigen is only intended to be used as a blocking agent to confirm antibody specificity with the corresponding antibody, catalog number NBP2-53496. It is purified by IMAC chromatography, and the expected concentration is greater than 0.5 mg/ml

For Research Use Only.